{"id":83399,"date":"2021-09-08T19:00:21","date_gmt":"2021-09-08T23:00:21","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=83399"},"modified":"2021-09-08T19:00:21","modified_gmt":"2021-09-08T23:00:21","slug":"chief-medical-officer-for-england-ordered-the-nhs-to-give-alleged-covid-19-patients-lethal-doses-of-hydroxychloroquine","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=83399","title":{"rendered":"Chief Medical Officer for England ordered the NHS to give alleged Covid-19 patients lethal doses of Hydroxychloroquine"},"content":{"rendered":"

Chris Whitty ordered the NHS to give alleged Covid-19 patients lethal doses of Hydroxychloroquine to kill them and sabotage trials \u2013 now the fate of the nations children rests in his hands<\/h1>\n

BY DAILY EXPOSE<\/p>\n

On April 1st 2020, the Chief Medical Officers of England, Scotland, Wales and N. Ireland, and the National Medical Director Stephen Powis\u00a0signed a message sent to their NHS colleagues<\/a>\u00a0to ask that every effort was made to enroll COVID-19 patients in the national priority clinical trials.<\/strong><\/p>\n

By David James<\/em><\/p>\n

Those trials were:<\/p>\n

PRINCIPLE (higher risk patients in primary care trial).
\nRECOVERY (in hospital trial)
\nREMAP-CAP (critically ill patient trial)<\/p>\n

Hydroxychloroquine was one of the drugs being trialled. In the RECOVERY Trial and the REMAP-CAP Trial<\/a>\u00a0they used an extremely high and potentially lethal dose: 800 mg at 0 and 6 hours followed by 400 mg at 12 hours and then every 12 hours for up to nine additional days. A patient was therefore given 2,400 mg in the first 24 hours of treatment.<\/p>\n

\n
\"\"<\/figure>\n<\/div>\n

Read trial document here.<\/em><\/a><\/p>\n

According to David Jayne, professor of clinical autoimmunity at Cambridge University:<\/p>\n

\u201cHydroxychloroquine overdose is associated with cardiovascular, neurological, and other toxicities, occurring with doses over 1500 mg, and higher doses are associated with fatality.\u201d<\/p>\n

In an article for the BMJ found\u00a0here\u00a0<\/a>co-head of the Recovery Trial Martin Landray explained:<\/p>\n

\u201cThe dose comes from modelling by Nick White, professor of tropical medicine at the University of Oxford, and his team, who have extensive experience with this drug.\u201d<\/p>\n

Sir Nicholas White was involved in the WHO\u2019s \u201cInformal consultation on the potential role of chloroquine in the clinical management of COVID 19 infection\u201d on March 13th. Also present were 5 \u201cExperts\u201d affiliated with the Bill & Melinda Gates Foundation. The\u00a0WHO\u2019s SOLIDARITY Trial used the same dose for hydroxychloroquine\u00a0<\/a>as the RECOVERY & REMAP-CAP Trials.<\/p>\n

Chinese scientists had already recommended a much lower and safer dose\u00a0<\/a>on March 9th 2020:<\/p>\n

\u201ca loading dose of 400 mg twice daily of hydroxychloroquine sulfate given orally, followed by a maintenance dose of 200 mg given twice daily for 4 days is recommended for SARS-CoV-2 infection\u201d<\/p>\n

The RECOVERY trial enrolled it\u2019s first patient on March 19th (see from 9th minute onwards):<\/p>\n

\n